Illicit drug use was estimated to cost the United States economy $193 billion dollars in health care, lost productivity, crime, incarceration, and drug enforcement in 2007.1
Economic costs climb even higher when factoring in both alcohol abuse2 and the epidemic of prescription medication abuse, particularly opioid analgesics.3 While these statistics are staggering, it is the impact on families that is the most worrisome. Substance abuse tears families apart and leaves young children vulnerable to repeating the abusive behaviors.4
Kashi is committed to the goal of recovery. To that end, we offer objective, unbiased drug-testing programs for healthcare providers who have patients at risk of substance abuse, currently in crisis, or are on the road to recovery. Our drug testing enables healthcare providers to make more accurate diagnoses and treatment decisions when it comes to substance abuse. It provides transparency for monitoring treatment adherence. Furthermore, drug testing may enhance patient safety by preventing possible harmful drug interactions and adverse reactions before they occur.
Kashi Toxicology offers an extensive menu dedicated to urine drug testing. All of our tests offer easy collection, accurate laboratory services, customized reporting, and one-on-one support.
Benefits to the clinician include:
- Providing clinical data that supports ongoing treatment and helps identify possible relapse
- Monitoring adherence to prescription medication-assisted treatments
- Detecting the use of non-prescribed medications and illicit substances
- Monitoring for alcohol and tobacco use
- Uncovering designer drugs and emerging substances of abuse such as synthetic cannabinoids (spice) and synthetic cathinones (bath salts)
- Detecting potentially harmful drug metabolites and drug-to-drug interactions before they occur
- Offering accurate test results with drug-specific information
Make Kashi's testing services part of your treatment planning.
- U.S. Department of Justice, National Drug Intelligence Center. The Economic Impact of Illicit Drug Use on American Society. Washington D.C. 2011:1-108.
- Rehm J et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009; 373(9682):2223-33.
- U.S. Department of Health and Human Services. Addressing Prescription Drug Abuse in the United States. Washington D.C. 2013:1-36. http://www.cdc.gov/HomeandRecreationalSafety/pdf/HHS_Prescription_Drug_Abuse_Report_09.2013.pdf
- Center for Substance Abuse Treatment. Chapter 2 Impact of Substance Abuse on Families. In: Substance Abuse Treatment and Family Therapy. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); 2004. Available at: http://www.ncbi.nlm.nih.gov/books/NBK64258/.